Protara Therapeutics | 4:持股变动声明-股东 Opaleye Management Inc.
Protara Therapeutics | 4:持股变动声明-股东 Opaleye Management Inc.
Protara Therapeutics | 4:持股变动声明-股东 Opaleye Management Inc.
Protara Therapeutics | 4:持股变动声明-股东 Opaleye Management Inc.
Protara Therapeutics | 4:持股变动声明-股东 Opaleye Management Inc.
Protara Therapeutics | 4:持股变动声明-董事 Flannelly Barry P
Protara Therapeutics | 4:持股变动声明-董事 Smith Cynthia
Protara Therapeutics | 4:持股变动声明-董事 Solomon Michael Edward
Protara Therapeutics | 4:持股变动声明-董事 SARGEN GREGORY
Protara Therapeutics | 4:持股变动声明-董事 Levy Richard S
Protara Therapeutics | 4:持股变动声明-董事 Huang Jane
Protara Therapeutics | 4:持股变动声明-董事 GARCEAU ROGER
Protara Therapeutics | 4:持股变动声明-董事 BESHAR LUKE M
Protara Therapeutics | 4:持股变动声明-股东 Opaleye Management Inc.
Protara Therapeutics | 4:持股变动声明-股东 Opaleye Management Inc.
Protara Therapeutics | 4:持股变动声明-股东 Opaleye Management Inc.
Protara Therapeutics | 4:持股变动声明-股东 Opaleye Management Inc.
Protara Therapeutics | SC 13G:超过5%持股股东披露文件-RA Capital Management, L.P.(9.99%),Peter Kolchinsky(9.99%)等
Protara Therapeutics | SC 13G:超过5%持股股东披露文件-Citadel Advisors LLC(5.7%),Citadel Advisors Holdings LP(5.7%)等
Protara Therapeutics | SC 13G:超过5%持股股东披露文件-CVI Investments, Inc.(5.3%),Heights Capital Management, Inc.(5.3%)
暂无数据